Early Initiation of Tafolecimab for Patients With Acute Coronary Syndromeundergoing Percutaneous Coronary Intervention in Chinese Population

Clinical trial NCT06096909 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06096909
Sponsor: China National Center for Cardiovascular Diseases
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Acute Coronary Syndrome Non ST Segment Elevation Acute Coronary Syndrome

Start date: 2023-11-01
Primary completion: 2025-11-01
Enrollment: 3684

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.